Orasure Technologies (OSUR) Cash from Investing Activities (2010 - 2025)
Orasure Technologies (OSUR) posted Cash from Investing Activities of -$821000.0 for Q3 2025, up 57.59% sequentially from -$1.9 million in Q2 2025, and down 111.2% YoY from $7.3 million in Q3 2024.
Orasure Technologies (OSUR) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Cash from Investing Activities for 16 years, with the latest figure at -$821000.0 in Q3 2025.
- Quarterly Cash from Investing Activities fell 111.2% year-over-year to -$821000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$7.9 million (down 164.52% YoY) and the FY2024 annual result came in at -$39.0 million, down 158.99% from the prior year.
- Cash from Investing Activities grew to -$821000.0 in Q3 2025 per OSUR's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $37.2 million in Q2 2023 and troughed at -$46.5 million in Q1 2024.
- A 5-year average of $2.1 million and a median of -$821000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities jumped 507.41% in 2022, then sank 4679.53% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$6.3 million in 2021, then surged by 507.41% to $25.6 million in 2022, then advanced by 19.48% to $30.6 million in 2023, then sank by 117.98% to -$5.5 million in 2024, then surged by 85.05% to -$821000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$821000.0, -$1.9 million, and $370000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -821,000.00 |
| Sep 30, 2025 | -821,000.00 |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 370,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Dec 31, 2024 | -5.49 Mn |
| Dec 31, 2024 | -5.49 Mn |
| Sep 30, 2024 | 7.33 Mn |
| Sep 30, 2024 | 7.33 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Mar 31, 2024 | -46.53 Mn |
| Mar 31, 2024 | -46.53 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Sep 30, 2023 | -2.57 Mn |
| Sep 30, 2023 | -2.57 Mn |
| Jun 30, 2023 | 37.16 Mn |
| Jun 30, 2023 | 37.16 Mn |